Novopyxis

Novopyxis is a biotechnology company developing novel anti-inflammatory therapeutics and interventions.

Novopyxis is a biotechnology company developing novel anti-inflammatory therapeutics and interventions. The Company is made of a diverse set of scientists, engineers, mathematicians, data scientists, and entrepreneurs who are experienced in understanding complex systems, discovering solutions, and bringing them to the marketplace. The current focus is on treatment for neurological and metabolic conditions which result from complications related to inflammatory issues ranging from ALS to cystic fibrosis. The team leverages their training at the Massachusetts Institute of Technology, the Johns Hopkins University, University of Chicago, and Columbia University, as well as advisory specialists from the VA Hospital System, Los Alamos National Labs, Johns Hopkins and MIT to turn these ideas into reality.